Aixial is a global CRO who have been conducting rare disease and orphan drug clinical trials since 2006. With deep expertise and a wealth of experience Aixial is well placed to support pharmaceutical and biotech companies by offering a comprehensive range of services, including regulatory guidance, patient recruitment, data management, and clinical monitoring. Aixial’s experienced team excels in navigating the complexities of rare and orphan drug trials, ensuring efficient study design, fast timelines and optimized results. Their proven track record in overcoming the unique challenges of these specialised trials makes them a trusted partner for companies developing treatments for rare diseases and orphan drugs.